SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRotork Regulatory News (ROR)

Share Price Information for Rotork (ROR)

Share Price is delayed by 15 minutes
Get Live Data
305.60    2.00 (0.66%)
Bid:
305.40
Ask:
306.00
Spread: 0.60 (0.196%)
Market Cap: £2.49b
ROR Live PriceLast checked at - London Stock Exchange

Intraday Rotork Share Chart

Share Buy-Back Programme

27 Jun 2024 18:01

RNS Number : 2414U
Rotork PLC
27 June 2024
 

 

Rotork plc

Share buy-back programme - Tranche 3

27 June 2024

 

As announced at the preliminary results on 5 March 2024, Rotork plc ('Rotork' or the 'Company') commenced a share buyback programme (the 'Programme') to repurchase ordinary shares of 0.5 pence each in the capital of the Company ('Ordinary Shares') of up to £50 million (excluding stamp duty and expenses). Our financial flexibility enables us to pursue strategic investments and we remain active in looking for suitable opportunities, consistent with our Growth+ strategy.

 

The third tranche will be carried out through an irrevocable non-discretionary agreement with Morgan Stanley & Co. International Plc ('MS'), pursuant to which MS shall purchase Ordinary Shares as riskless principal (and not as agent of Rotork) for the subsequent sale on to, and purchase by, Rotork. The third tranche of the Programme will commence on the later of 8 July 2024 and the day following the completion of the second tranche and end no later than 6 September 2024. The aggregate purchase price of all Ordinary Shares acquired under the third tranche of the Programme will be no greater than £10 million (excluding stamp duty and expenses). Any purchases under the Programme will take place in accordance with (and subject to the limits prescribed by) the Company's general authority to repurchase Ordinary Shares granted by its shareholders at the Company's 2024 Annual General Meeting (the '2024 Authority'). The maximum number of Ordinary Shares that the Company is authorised to purchase under the 2024 Authority is 86,125,908 Ordinary Shares. MS will make its trading decisions in relation to the Ordinary Shares independently of, and uninfluenced by, the Company. Any Ordinary Shares purchased by the Company will be cancelled.

 

Any purchase of Ordinary Shares in relation to the Programme will be carried out on the London Stock Exchange and any other UK recognised investment exchange which may be agreed, in accordance with pre-set parameters and in accordance with (and subject to limits prescribed by) the Company's 2024 Authority, Chapter 12 of the Financial Conduct Authority's Listing Rules, Article 5(1) of Regulation (EU) No. 596/2014 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018) and Commission Delegated Regulation (EU) 2016/1052 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018). Rotork will announce any market repurchases of Ordinary Shares no later than 7.30 a.m. on the business day following the calendar day on which the repurchase occurred.

 

Enquiries to:

 

Nick Hasell/Susanne Yule, FTI Consulting

Tel: +44 (0)20 3727 1340

Andrew Carter, Investor Relations Director, Rotork Plc

Tel: +44 (0) 1225 733 200

 

Legal Entity Identifier: 213800AH5RZIHGWRJ718

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSFLFERRTIDFIS
Date   Source Headline
2nd Jun 202111:00 amRNSDirector Declaration
2nd Jun 202110:00 amRNSTotal Voting Rights
13th May 20214:06 pmRNSDirector/PDMR Shareholding
4th May 20213:36 pmRNSTotal Voting Rights
30th Apr 20211:30 pmRNSResult of AGM
30th Apr 20217:00 amRNSTrading update
14th Apr 202110:00 amRNSDirector/PDMR Shareholding
12th Apr 20214:00 pmRNSDirector/PDMR Shareholding
1st Apr 20213:28 pmRNSTotal Voting Rights
31st Mar 20218:30 amRNS2020 Annual Report and Notice of 2021 AGM
25th Mar 20215:14 pmRNSDirector/PDMR Shareholding
12th Mar 20213:00 pmRNSDirector/PDMR Shareholding
9th Mar 20213:30 pmRNSDirector/PDMR Shareholding
9th Mar 20213:30 pmRNSDirector/PDMR Shareholding
3rd Mar 202111:34 amRNSTotal Voting Rights
2nd Mar 20217:00 amRNS2020 Full Year Results
1st Mar 202110:00 amRNSDirector Declaration
15th Feb 20215:41 pmRNSDirector/PDMR Shareholding
10th Feb 202111:00 amRNSHolding(s) in Company
1st Feb 20213:00 pmRNSTotal Voting Rights
26th Jan 20212:00 pmRNSHolding(s) in Company
12th Jan 20213:00 pmRNSDirector/PDMR Shareholding
5th Jan 202110:00 amRNSTotal Voting Rights
4th Jan 202110:00 amRNSDirector Declaration
15th Dec 20203:00 pmRNSHolding(s) in Company
11th Dec 20203:00 pmRNSDirector/PDMR Shareholding
1st Dec 20204:30 pmRNSTotal Voting Rights
1st Dec 20203:00 pmRNSHolding(s) in Company
26th Nov 20204:00 pmRNSHolding(s) in Company
26th Nov 20201:30 pmRNSDirectorate Change
25th Nov 20207:00 amRNSTrading update
18th Nov 20203:30 pmRNSHolding(s) in Company
11th Nov 20203:00 pmRNSDirector/PDMR Shareholding
2nd Nov 20203:00 pmRNSTotal Voting Rights
23rd Oct 20203:00 pmRNSHolding(s) in Company
14th Oct 20203:00 pmRNSHolding(s) in Company
13th Oct 20204:14 pmRNSDirector/PDMR Shareholding
1st Oct 20203:13 pmRNSTotal Voting Rights
29th Sep 20208:00 amRNSDirectorate Change
15th Sep 20203:00 pmRNSHolding(s) in Company
11th Sep 20203:00 pmRNSDirector/PDMR Shareholding
3rd Sep 20203:00 pmRNSTotal Voting Rights
25th Aug 20203:00 pmRNSHolding(s) in Company
12th Aug 20203:00 pmRNSDirector/PDMR Shareholding
4th Aug 20203:00 pmRNSTotal Voting Rights
4th Aug 20203:00 pmRNSHolding(s) in Company
4th Aug 20207:00 amRNS2020 Half Year Results
21st Jul 20203:00 pmRNSHolding(s) in Company
15th Jul 20208:37 amRNSDirector/PDMR Shareholding
2nd Jul 202012:58 pmRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.